Join Now

Yearly Archives: 2020

RenalytixAI Receives California Commercial Lab Certification

By Denise Bell | Published September 25, 2020

RenalytixAI – a BioUtah member – announced on Tuesday that it has received a California Clinical Laboratory License from the California Department of Health for its clinical laboratory in Salt Lake City, Utah. This means that KidneyIntelX™ may now be used to report risk assessment of progressive decline in kidney function for patients in California with […]

Posted in BioUtah News, Utah's Life Sciences Companies | Leave a comment

Utah COVID-19 Grant Programs Update

By Denise Bell | Published September 18, 2020

BioUtah is pleased to provide the life sciences community with a current summary of state COVID-19 initiatives and grant programs managed by the Governor’s Office of Economic Development. Visit business.utah.gov/coronavirus to learn more. Coronavirus Prevention Messaging Grants Grants of up to $50,000, $75,000 or $250,000 for social media, targeted audience and mass media campaigns, respectively, […]

Posted in Policy News | Leave a comment

Trump Administration Releases COVID-19 Vaccine Distribution Strategy

By Denise Bell | Published September 18, 2020

The Administration on Wednesday released a detailed plan for the distribution of free COVID-19 vaccines beginning next year. The plan would prioritze vaccines for healthcare workers, essential employees, and high-risk indiividuals. From there, distribution would be expanded to the broader population. The plan includes two documents: documents: A strategic distribution overview along with an interim […]

Posted in COVID-19 Updates, Federal News, Policy News | Leave a comment

Fulgent Genetics Lands Utah COVID-19 Testing Contract

By Denise Bell | Published September 18, 2020

TestUtah has some new twists. Following the expiration of certain state contracts September 1, the Utah Department of Public Health has changed direction and contracted with a Los Angeles laboratory, Fulgent Genetics, to process COVID-19 testing for Utahns under the state’s coronavirus testing initiative. The test, which has received EUA from the FDA, will be […]

Posted in BioUtah COVID-19 Analysis, COVID-19 Updates, State News | Leave a comment

The Point Kick Off

By Denise Bell | Published September 18, 2020

On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning efforts to redevelop the site of the Utah State Prison (The Point) in Draper. Many of our industry leaders are participating on The Point’s Education, Research and Innovation working group – Randy Rasmussen (former BioFire CEO), Gary […]

Posted in BioUtah News, Industry News, State News, Utah's Life Sciences Companies | Leave a comment

RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System

By Denise Bell | Published September 18, 2020

Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the Mount Sinai Health System. This means that KidneyIntelX risk assessment of progressive decline in kidney function or kidney failure, including education support for treating clinicians, is now commercially available for patients with early stage diabetic kidney disease […]

Posted in BioUtah News, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | Leave a comment

2020 Bench to Bedside Participants Announced

By admin | Published September 18, 2020

Courtesy of University of Utah Academics & Research Postponed from its original in-person event last April, the annual medical innovation challenge has moved entirely online this year. Tuesday September 8, 2020 | Salt Lake City, UT Nearly five months after postponing the original in-person event in response to COVID-19, the 10th Annual Bench to Bedside competition […]

Posted in Industry News | Leave a comment

President Signs New Executive Order on Drug Pricing

By Denise Bell | Published September 18, 2020

President Trump issued a new “Most-Favored-Nations” (MFN) executive order on September 13 that links U.S.-paid Medicare drug prices to those paid by other foreign countries. BIO President and CEO, Dr. Michelle McMurry-Heath, called the President’s action a “reckless scheme” that would hurt vulnerable seniors. The new order includes both Medicare Part B and Part D […]

Posted in Policy News | Leave a comment

Recursion Partners with Bayer to Accelerate Drug Discovery, Secures Series D Funding

By Denise Bell | Published September 11, 2020

In a double header of good news, Salt Lake City -based Recursion announced on Wednesday that the company has entered into a strategic collaboration agreement with Bayer to discover and develop new treatments for fibrotic diseases of the lung, kidney, heart and more. The agreement leverages Recursion’s AI drug discovery platform and Bayer’s small molecule […]

Posted in Policy News | Leave a comment

Co-Diagnostic Enters into Agreement with Arches Research to Expand COVID-19 Testing

By Denise Bell | Published September 11, 2020

Co-Diagnostics, a Salt Lake City company that was out of the gate early with a molecular COVID-19 test, announced this week that it has entered into an agreement with another Salt Lake City based company, Arches Research, a CLIA laboratory and subsidiary of PolarityTE to expand Arches’ COVID-19 testing services using Co-Diagnostics’ Logix Smart™ COVID-19 […]

Posted in COVID-19 Updates | Leave a comment

BioUtah Member Horizon Therapeutics Named to PEOPLE’s “50 Companies That Care” List

By Denise Bell | Published September 11, 2020

Horizon Therapeutics has been named to PEOPLE’s 2020 “50 Companies That Care” list. Partnering with Great Place to Work, PEOPLE identified the top U.S. companies that went above and beyond in responding to the pandemic.The list, focused on employers with 1,000 or more employees, will be featured in the Sept. 14, 2020 print issue of […]

Posted in Industry News | Leave a comment

Drug Companies Pledge to Stand with Vaccine Science

By Denise Bell | Published September 11, 2020

The CEOs of nine pharmaceutical manufacturers working on COVID-19 vaccines – AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and Sanofi – signed a pledge Tuesday to “uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines.” In the pledge, the […]

Posted in COVID-19 Updates | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members